LDHA and neoplasm: We also demonstrated functional overreliance on glycolysis by tumor cells compared with T cells, both in vitro using human and mouse cells and ex vivo from murine syngeneic tumor models, identifying a therapeutic window for preferentially targeting LDHA in tumor cells.